Comparison of three roche hepatitis B virus viral load assay formats

Journal of Clinical Microbiology

Volumn 50, Issue 7, 2012, Pages 2337-2342

  Pyne, Michael T ^a   Vest, Lauren ^b   Clement, Jennifer ^b   Lee, Jessica ^b   Rosvall, Jessica R ^b,e   Luk, Kevin ^c   Rossi, Michael ^c   Cobb, Bryan ^c   Hillyard, David R ^a,d  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b ARUP LABORATORIES   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e Roche Diagnostics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; AUTOMATED COBAS AMPLIPREP COBAS TAGMAN HBV TEST; AUTOMATION; BIOASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MANUAL COBAS TAGMAN HBV TEST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TOTAL NUCLEIC ACID ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TITRATION;

AUTOMATION; DIAGNOSTIC ERRORS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIMIT OF DETECTION; REPRODUCIBILITY OF RESULTS; VIRAL LOAD;

EID: 84862733605     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00746-12     Document Type: Article

References (12)

1. Berger A, et al. 2010. Detection and quantitation of HBV DNA in miniaturized samples: multi centre study to evaluate the performance of the COBAS AmpiPrep/COBAS Taqman hepatitis B virus (HBV) test v2.0 by the use of plasma or serum specimens. J. Virol. Methods 169:404-408.
2. Bhattacharya D, Thio CL. 2010. Review of hepatitis B therapeutics. Clin. Infect. Dis. 51:1201-1208.
3. Caliendo AM, et al. 2011. Multilaboratory evaluation of real-time PCR tests for hepatitis B virus DNA quantification. J. Clin. Microbiol. 49:2854-2858.
4. Chevaliez S, Bouvier-Alias M, Laperche S, Hézode C, Pawlotsky J-M. 2010. Performance of version 2.0 of the Cobas AmpliPrep/Cobas TaqMan real-time PCR asay for hepatitis B virus DNA quantification. J. Clin. Microbiol. 48:3641-3647.
5. Dienstag JL. 2008. Hepatitis B virus infection. N. Engl. J. Med. 359:1486-1500.
6. Goedel S, et al. 2009. Hepatitis B virus (HBV) genotype determination by the COBAS AmpliPrep/COBAS TaqMan HBV test, v2.0 in serum and plasma matrices. J. Clin. Virol. 45:232-236.
7. Hochberger S, et al. 2006. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan System. J. Clin. Virol. 35:373-380.
8. Lai M, Liaw Y-F. 2010. Chronic hepatitis B: past, present, and future. Clin. Liver Dis. 14:531-546.
9. Lok ASF, McMahon BJ. 2009. Chronic hepatitis B: update 2009. Wiley, Hoboken, NJ. http://www.aasld.org/practiceguidelines/documents/ bookmarked%20practice%20guidelines/chronic-hep-b-update-2009%208-24-2009.pdf.
10. Ronsin C, Pillet A, Bali C, Denoyel G-A. 2006. Evaluation of the COBAS AmpliPrep-Total Nucleic Acid Isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay. J. Clin. Microbiol. 44:1390-1399.
11. Weiss J, et al. 2004. Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J. Clin. Virol. 30:86-93.
12. Yuen M-F, Lai C-L. 2011. Treatment of chronic hepatitis B: evolution over two decades. J. Gastroenterol. Hepatol. 26(Suppl. 1):138-143.